Charles River Laboratories | CRL

Stock Price
163.99
Daily Change
1.68 1.04%
Monthly
9.09%
Yearly
-12.63%
Q3 Forecast
162.63

Peers Price Chg Day Year Date
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
Elevance Health 313.64 5.59 1.81% -42.30% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Bruker 30.83 1.04 3.49% -51.84% Sep/05
Cardinal Health 149.56 0.22 0.15% 33.55% Sep/05
Cigna 305.31 1.28 0.42% -13.66% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
CVS Health 73.78 0.09 0.12% 27.82% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Galapagos 28.44 1.84 6.92% 11.53% Sep/06
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Humana 307.92 -4.08 -1.31% -13.89% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
Incyte 86.64 1.20 1.40% 41.43% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
McKesson 687.40 -4.05 -0.59% 36.29% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Mettler Toledo International 1,305.71 17.92 1.39% -5.26% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
UnitedHealth 315.39 5.01 1.61% -47.18% Sep/05
United Therapeutics 400.52 20.05 5.27% 15.88% Sep/05
Waters 306.32 6.63 2.21% -6.72% Sep/05
West Pharmaceutical Services 250.73 3.19 1.29% -15.66% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05

Indexes Price Day Year Date
US400 3297 16.31 0.50% 12.16% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05

Charles River Laboratories traded at $163.99 this Friday September 5th, increasing $1.68 or 1.04 percent since the previous trading session. Looking back, over the last four weeks, Charles River Laboratories gained 9.09 percent. Over the last 12 months, its price fell by 12.63 percent. Looking ahead, we forecast Charles River Laboratories to be priced at 162.63 by the end of this quarter and at 158.61 in one year, according to Trading Economics global macro models projections and analysts expectations.

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.